Atlas Trials

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B

Clinical trial NCT02982837 · UNKNOWN

Trial details

NCT number
NCT02982837
Sponsor
King Abdullah International Medical Research Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B
Start date
2015-03-01
Primary completion
2019-03-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.